Clinical Trial: A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07174310) titled 'A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease' on Sept. 12.

Brief Summary: The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics (PK) of prasinezumab compared with placebo in participants with early-stage Parkinson's disease (PD) on stable symptomatic monotherapy with levodopa.

Study Start Date: Dec. 31, 2025

Study Type: INTERVENTIONAL

Condition: Parkinson's Disease

Intervention: DRUG: Prasinezumab

Participants will receive Prasinezumab as an IV Infusion as per the schedule mentioned in the protocol.

DRUG: Place...